Professional Documents
Culture Documents
Core-Shell Magnetite Nanoparticles Surface Encapsulated With Smart Stimuli Responsive Polymer
Core-Shell Magnetite Nanoparticles Surface Encapsulated With Smart Stimuli Responsive Polymer
We describe here the synthesis of a novel magnetic drug-targeting carrier characterized by a core-shell structure.
The core-shell carrier combines the advantages of a magnetic core and the stimuli-responsive property of the
thermosensitive biodegradable polymer shell (e.g., an on-off mechanism responsive to external temperature change).
The composite nanoparticles are ∼8 nm in diameter with ∼3 nm shell. The lower critical solution temperature (LCST)
See https://pubs.acs.org/sharingguidelines for options on how to legitimately share published articles.
is ∼38 °C as determined by UV-vis absorption spectroscopy. The carrier is composed of cross-linked dextran grafted
with a poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) [dextran-g-poly(NIPAAm-co-DMAAm)] shell and
Downloaded via UNIV FED FLUMINENSE on October 2, 2019 at 17:54:54 (UTC).
superparamagnetic Fe3O4 core. Fourier transform infrared spectroscopy (FTIR) confirmed the composition of the
carrier. The synthesized magnetic carrier system has potential applications in magnetic drug-targeting delivery and
magnetic resonance imaging.
Introduction the ability to control the size range of nanoparticles from a few
In recent years, the usage of magnetic nanoparticles has nanometers up to tens of nanometers makes them comparable
attracted significant interest in biomedicine and biomedical to a virus (20-450 nm), a protein (5-50 nm), or a gene (2 nm
engineering for applications including magnetic carriers for drug wide and 10-100 nm long),15 enabling them to be in close
delivery systems and contrast enhancement agents in magnetic proximity to a biological entity of interest.
resonance imaging (MRI) for diagnostics. The motivation for In spite of the above advantages, there is a need to functionalize
the use of magnetic nanoparticles is related to their superpara- nanoparticles with a polymer for applications involving drug
magnetic characteristics, higher saturation magnetization, and delivery systems and MRI, in the absence of which they will
good biocompatibility.1-3 Superparamagnetic nanoferrites ex- tend to aggregate and have short blood half-life in circulation.2
hibiting higher magnetization and good biocompatibility can be Agglomeration of nanoparticles with large surface-to-volume
appropriately used as magnetic drug-targeting carriers for ratio will result in the loss of magnetic characteristics, decrease
hyperthermia,4-8 controlled drug release,9-11 and as contrast of surface activity, and rapid elimination by macrophages or the
enhancement agents in MRI.12-14 An important attribute of reticular endothelial system (RES) before they actually arrive at
superparamagnetic nanoparticles is that magnetism is not retained the target cells. Also, these drawbacks prevent effective loading
upon removal of the applied external magnetic field. Additionally, of drug or cell-labeling molecules.16,17 In view of the afore-
mentioned reasons, it is desired that the magnetic nanoparticles
* dmisra@louisiana.edu. are encapsulated with a polymer shell with the magnetic
† Center for Structural and Functional Materials and Department of
nanoparticles as the core. Adopting a core-shell structure, besides
Chemical Engineering.
§ Department of Chemistry. preventing agglomeration of nanoparticles and cleaning of
(1) Ito, A.; Shinkai, M.; Honda, H.; Kobayashi, T. J. Biosci. Bioeng. 2005, macrophages or RES, additionally provides novel properties that
100, 1. are suitable for biological applications such as biocompatibility,
(2) Guptaa, A. K.; Gupta, M. Biomaterials 2005, 26, 3995.
(3) Sunderland, C. J.; Steiert, M.; Talmadge, J. E.; Derfus, A. M.; Barry, S.
drug-loading ability, and controlled drug release.18 It is envisaged
E. Drug DeV. Res. 2006, 67, 70. that the surface-modified nanoparticles can be used as contrast
(4) Jordan, A.; Scholz, R.; Wust, P.; Hling, H. F.; Felix, R. J. Magn. Magn. enhancement agents and magnetic drug-targeting carriers,
Mater. 1999, 201, 413.
(5) Babincová, M.; Leszczynska, D.; Sourivong, P.; Ĉiĉmanec, P.; Babinec, enabling the response of drug release to be monitored over time
P. J. Magn. Magn. Mater. 2001, 225, 109. during treatment, for instance, in the case of cancer,1 where
(6) Jordan, A.; Scholz, R.; Klaus, M. H.; Johannsen, M.; Wust, P.; Nadobny, site-specific treatment is preferred to avoid side effects and
J.; Schirra, H.; Schmidt, H.; Deger, S.; Loening, S.; Lanksch, W.; Felix, R. J.
Magn. Magn. Mater. 2001, 225, 118. toxicity.
(7) Moroz, P.; Jones, S. K.; Winter, J.; Bruce, N. J. Surg. Oncol. 2001, 78, In general, for functionalization of magnetic nanoparticles,
22.
(8) Kong, G.; Braun, R. D.; Dewhirst, M. W. Cancer Res. 2001, 61, 3027. inorganic materials (e.g., silica, gold), polymers (e.g., poly-
(9) Detlef, M. S.; Thomas, S. R. J. Magn. Magn. Mater. 2006, 302, 267. (ethylene glycol) (PEG), poly(vinyl alcohol) (PVA), poly(lactic-
(10) Sonvico, F.; Mornet, S.; Vasseur, S.; Dubernet, C.; Jaillard, D.; Degrouard,
J.; Hoebeke, J.; Duguet, E.; Colombo, P.; Couvreur, P. Bioconjugate Chem. 2005,
16, 1181. (15) Pankhurst, Q. A.; Connolly, J.; Jones, S. K.; Dobson, J. J. Phys. D: Appl.
(11) Jain, T. K.; Morales, M. A.; Sahoo, S. K.; Leslie-Pelecky, D. L.; Phys. 2003, 36, R167.
Labhasetwar, V. Mol. Pharm. 2005, 2, 194. (16) Neuberger, T.; Schöpf, B.; Hofmann, H.; Hofmann, M.; von Rechenberg,
(12) Kohler, N.; Sun, C.; Wang, J.; Zhang, M. Langmuir 2005, 21, 8858. B. J. Magn. Magn. Mater. 2005, 293, 483.
(13) Kangarlu, A.; Ibrahim, T. S.; Shellock, F. G. Magn. Reson. Imaging 2005, (17) Rana, S.; Gallo, A.; Srivastava, R. S.; Misra, R. D. K. Acta Biomater.
23, 53. 2007, 3, 233.
(14) Mulder, W. J. M.; Strijkers, G. J.; van Tilborg, G. A. F.; Griffioen, A. (18) Kohler, N.; Fryxell, G. E.; Zhang, M. Q. J. Am. Chem. Soc. 2004, 126,
W.; Nicolay, K. NMR Biomed. 2006, 19, 142. 7206.
co-glycolic acid) (PLGA)), surfactants (e.g., oleic acid, sodium can be tuned to be above the body temperature by incorporating
oleate, dodecylamine), biomolecules (e.g., dextran, chitosan) can comonomer units, such as N,N-isopropylacrylamide, rendering
be considered.2 However, in recent years, thermosensitive PNIPAAm-based materials as potential candidates for drug
polymers are being considered to enhance drug-loading ability delivery applications. If we can control the LCST such that it
and controlling drug release because of the large inner volume is greater than the body temperature by a suitable external
and ability to manipulate permeability, and more importantly, stimulus, then the mechanism can be utilized for the drug-
they can respond to the external stimulus with an on-off switch controlled release systems. However, the disadvantage is that
mechanism.19-21 In this regard, liposomes with biocompatibility the PNIPAAm homopolymer is not biodegradable.
and poly(N-isopropylacrylamide) (PNIPAAm)-based polymers More recently, the LCST and enzymatic degradation of dextran-
are two potential temperature-responsive materials. Liposomes g-poly(N-isopropylacrylamide-co-N,N-dimethylacrylamide) [dex-
are characterized by a concentric bilayered vesicle structure tran-g-poly(NIPAAm-co-DMAAm)] have been studied.30 The
consisting of amphiphilic phospholipids that surround an aqueous grafted copolymers in phosphate buffer solution (PBS) exhibited
core and can be utilized for loading drugs and magnetic an LCST of ∼40 °C because of the thermosensitive nature of
nanoparticles. The size of liposomes is in the range 0.025-10 the grafted polymer. Also, the water-soluble dextran as the main
µm in diameter and can be designed with desired size and chain was biodegradable, and the degradation increased with a
morphology through process and composition modification.22 decrease in the graft length below the LCST, while enzymatic
On heating, phospholipid bilayers exhibit an endothermic degradation was independent of the graft length above the LCST.
transition at a specific temperature (Tc), which is lower than the This “smart” behavior and enzymatic degradation is particularly
melting point. Below the Tc, the phospholipid bilayers are attractive in controlled drug delivery and biomedical applications.
characterized by a gel state, and above the Tc, they are in a liquid The specific and controlled delivery of drugs to the target site
crystalline state.23 In the past two decades, there has been is essential to increase their effectiveness and performance,
significant progress in the use of liposome-mediated delivery of decrease side effects on healthy tissues, and promote the rate of
therapeutic agents from the laboratory to the clinic.24,25 However, action.
one of the drawbacks with targeted liposomes is that the processing Thus, combining the stimuli-responsive “smart” behavior and
of synthetic liposomes is complex and involves high cost, while enzymatic degradation of the biopolymers with properties of
the natural liposomes do not have a defined phase transformation magnetic nanoparticles is a viable approach to fabricate a drug
temperature. In view of this disadvantage, their usage has been carrier. This system will serve as an “effective drug delivery
limited. system with targeting and controlled drug release”. The objective
The PNIPAAm homopolymer is a synthetic thermosensitive of the work presented here is to describe the synthesis of a new
polymer with a lower critical solution temperature (LCST) of and novel drug-targeting delivery system that innovatively
32 °C in water. In aqueous solution, it is hydrated and expands combines the stimuli-responsive property of the thermosensitive
below the LCST, while it is hydrophobic and collapsed at biodegradable polymer with the advantages of magnetic nano-
temperatures greater than the LCST. This implies that it particles to develop a core-shell structure with a triggered release
experiences a sharp coil-globule transition in water at the LCST, mechanism. To our understanding, such a smart system is being
transforming from a hydrophilic state below the LCST to a proposed for the first time. Monodisperse magnetic Fe3O4
hydrophobic state above the LCST.26,27 This behavior is attributed nanoparticles constituting the core are encapsulated with the
to the fact that, at temperatures lower than the LCST, the thermosensitive biodegradable polymers as a drug carrier. The
predominantly intermolecular hydrogen bonding between the magnetic drug-targeting carrier has the following advantages:
PNIPAAm chains and water molecules results in the PNIPAAm (a) the LCST of a given polymer can be controlled above human
chains adopting a water-soluble coiled structure, while above body temperature by incorporation of comonomer units of
the LCST, intermolecular hydrogen bonding between CdO and N-isopropylacrylamide; (b) the magnetic drug carrier can be
NsH groups in the PNIPAAm chains makes the chains adopt targeted to a selected site through the use of external magnetic
a compact and collapsible structure, decreasing their water field, and the encapsulated drug can be subsequently released
solubility.26,27 The LCST of PNIPAAm can be effectively from the thermosensitive biodegradable polymer in response to
controlled by incorporating hydrophilic charged units, such as heat generated from an alternative magnetic field; and (c) the
methacrylic acid (MAA), as well as hydrophobic units, such as drug carrier is biodegradable.
butyl methacrylate. Generally, the hydrophilic charged residues
tend to increase the LCST, while hydrophobic residues tend to Experimental Section
lower the LCST.28,29 The LCST of the PNIPAAm copolymer Materials. The chemicals used for the synthesis of the core-
shell nanoparticle system were iron(III) acetylacetonate (Fe(acac)3)
(19) Lai, C. Y.; Trewyn, B. G.; Jeftinija, D. M.; Jeftinija, K.; Xu, S.; Jeftinija, (99.9%), 1,2-dodecanediol (g90%), oleic acid (cis-9-octadecenoic
S.; Lin, V. S.-Y. J. Am. Chem. Soc. 2003, 125, 4451.
(20) Giri, S.; Trewyn, B. G.; Stellmaker, M. P.; Lin, V. S.-Y. Angew. Chem., acid 90%), oleylamine (cis-1-aminooctadecene >70%), diphenyl
Int. Ed. 2005, 44, 5038. ether (99%), absolute ethanol, hexane, tetrahydrofuran (g99%),
(21) Zhu, Y.; Shi, J.; Shen, W.; Dong, X.; Feng, J.; Ruan, M.; Li, Y. Angew. tetramethylammonium hydroxide (25%) in methanol, 11-aminoun-
Chem., Int. Ed. 2005, 44, 5083. decanoic acid (99%), and dichloromethane (99%). N,N-Dimethy-
(22) Kono, K. AdV. Drug DeliVery ReV. 2001, 53, 307.
(23) Zhang, L. F.; Granick, S. Nano Lett. 2006, 6, 694. lacrylamide (DMAAm, 99%) was purified by vacuum distillation
(24) Roux, E.; Lafleur, M.; Lataste, EÄ .; Moreau, P.; Leroux, J-C. Biomac- at 82 °C/20 mmHg. N-Isopropylacrylamide (NIPAAm, 97%), methyl
romolecules 2003, 4, 240. 3-mercaptopropionate (g98.0%), 2 2′-azobisisobutyronitrile (AIBN,
(25) Bos, C.; Lepetit-Coiffé, M.; Quesson, B.; Moonen, C. T. W. Magn. Reson. 98%), methanol (99.9%), diethyl ether (99.9%), hydrazine mono-
Med. 2005, 54, 1020.
(26) Alarcón, C. D. L. H.; Pennadam, S.; Alexander, C. Chem. Soc. ReV. 2005, hydrate (g98.0%), dialysis membrane (MWCO e 1200), dextran
34, 276. (Mn ) 10 000 from BioWorld-Serving Life-Sciences and Biotech-
(27) Twaites, B.; Alarcón, C., de las, H.; Alexander, C. J. Mater. Chem. 2005, nology Industries Worldwide, USA), dimethylaminopyridine (DMAP,
15, 441. g99%), and dimethyl sulfoxide (DMSO, g99.5%) were purchased
(28) You, Y. Z.; Hong, C. Y.; Pan, C. Y.; Wang, P. H. AdV. Mater. 2004, 16,
1953.
(29) Uludag, H.; Norrie, B.; Kousinioris, N.; Gao, T. Biotechnol. Bioeng. (30) Huh, K. M.; Kumashiro, Y.; Ooya, T.; Yui, N. Polym. J. 2001, 33,
2001, 73, 510. 108.
6344 Langmuir, Vol. 23, No. 11, 2007 Zhang et al.
from Sigma-Aldrich, except as indicated, and used as received without The second step involved transformation of STP-COOCH3 into
further purification. Pyridine (g99.0%) was dried over CaH2 (90- STP-NHNH2. The transformation reaction was performed through
95%) and distilled after refluxing for 3 h. 4-Nitrophenyl chloroformate a hydrazinolysis reaction. 40 mL of STP-COOCH3 methanol solution
(97%), 1,6-hexamethylenediamine (99.0%), dialysis membrane (MW was added dropwise to 10 mL of methanol solution containing
) 12 400) were also purchased from Sigma-Aldrich and used as excessive hydrazine monohydrate with stirring, followed by refluxing
received. for 5 h. The product was precipitated in excess diethyl ether. Then,
Preparation of Magnetite Nanoparticles. Fe3O4 nanoparticles it was dialyzed against water using a dialysis membrane (MWCO
with an average diameter of 5 nm were prepared using the approach e 1200) for 3 days and freeze-dried.
of high-temperature decomposition proposed by Sun.31 First, 20 mL The third step was preparation of dextran with 4-nitrophenyl
of biphenyl ether, 0.71 g (2 mmol) of iron(III) acetylacetonate, 2.25 chloroformate. The dextran was activated using 4-nitrophenyl
g (10 mmol) of 1,2-dodecanediol, 2.12 mL (6 mmol) of oleic acid, chloroformate in the catalysis of 4-dimethylaminopyridine (DMAP).
and 2.19 mL (6 mmol) of oleylamine were mixed in a 150 mL 250 mL mixing solution of DMSO/pyridine (volume ratio 1/1)
three-necked flask while magnetically stirring. The solution was containing dextran (1.0 g), 4-nitrophenyl chloroformate (4.35 g),
gradually heated to 200 °C under nitrogen atmosphere for 2 h. After and DMAP (0.20 g) was held at 0 °C for 8 h. After precipitation
2 h, the nitrogen flow was stopped, and the solution was heated at and washing with ethyl alcohol, the product was filtered and dried
∼260 °C for 1 h to reflux. During this process, the initial brown- at 50 °C.
black color of the solution gradually changed to dark black, indicating The final step concerned synthesis of the dextran-g-poly(NIPAAm-
synthesis of the magnetite nanoparticles. Subsequently, the resultant co-DMAAm). The graft copolymers were synthesized by a coupling
solution was cooled to room temperature, and 40 mL ethanol was reaction between the 4-nitrophenyl chloroformate-activated dextran
added to yield a black precipitate. The black Fe3O4 precipitate was and STP-NHNH2. 1.0 g of activated dextran and 0.76 g of STP-
separated by centrifuging at 15 000 rpm for 30 min. NHNH2 are dissolved in 60 mL of DMSO and allow to react at room
In order to purify the Fe3O4 nanoparticles and to prevent them temperature for 48 h. After precipitation in diethyl ether and drying
from aggregation, the following experimental steps were carried at 50 °C, the dried product was dialyzed (MW ) 12 400) against
out. The black precipitate was redispersed in 10 mL of hexane in deionized water for 3 days to remove unreacted STP-NHNH2 and
the presence of 50 µL of oleic acid and 50 µL of oleylamine to yield then freeze-dried.
a nontransparent homogeneous solution. The homogeneous solution Coating of Magnetic Nanoparticles with the Smart Polymer.
was again centrifuged at 6000 rpm for 10 min, and any particulate In the above aqueous colloid solution containing hydrophilic Fe3O4
residue was removed. The solution containing magnetic nanoparticles nanoparticles, 10 mg of the dextran-g-poly(NIPAAm-co-DMAAm)
was again precipitated with ethanol (20 mL), centrifuged at 10 000 thermosensitive polymer and the desired amount of 1,6-diamino-
rpm for 20 min, and redispersed in 10 mL of hexane and dried at hexane as cross-linker were added under sonication for 1 h at ∼50
60 °C for 24 h. The as-synthesized Fe3O4 colloid in hexane is °C. Since the dextran-g-poly(NIPAAm-co-DMAAm) thermosen-
hydrophobic and stable for nearly a year, while the dried Fe3O4 sitive polymer contains the active 4-nitrophenyl chlorofomate groups,
sample can be stable for several months. they can be cross-linked by 1,6-diaminohexane around the magnetic
The magnetic nanoparticles in biomedical application need to be core to form the core-shell structure. These Fe3O4 nanoparticles
hydrophilic; the hydrophobic Fe3O4 nanoparticles in hexane were encapsulated with biodegradable thermosensitive polymer were
transformed to hydrophilic Fe3O4 nanoparticles using a tetramethy- dialyzed in deionized water for 24 h to remove unreacted molecules.
lammonium 11-aminoundecanoate bipolar surfactant.31 Tetram- Characterization of Nanoparticles. To examine the morphology,
ethylammonium 11-aminoundecanoate was prepared by titrating a size range, and structure of the nanoparticles, the as-synthesized
methanolic suspension of 11-aminoundecanoic acid with methanolic Fe3O4 nanoparticles dispersed in hexane and smart polymer
tetramethylammonium hydroxide, evaporating the solvent under encapsulated Fe3O4 nanoparticles dispersed in deionized water
reduced pressure, and recrystallizing in tetrahydrofuran. 15 mg of were placed onto a carbon-coated copper grid followed by drying
tetramethylammonium 11-aminoundecanoate and 50 µL of the in air. Transmission electron microscopy (TEM) studies were carried
hydrophobic Fe3O4 colloid in hexane were added in 2 mL of out using a Hitachi H-7600 microscope at an accelerating voltage
dichloromethane (CH2Cl2). After the brown mixture was sonicated of 100 kV in conjunction with selected area electron diffraction
for about 5 min, the Fe3O4 nanoparticles were precipitated. The (SAED).
dichloromethane solvent was removed, and the Fe3O4 nanoparticles Characterization of Polymers. To confirm the structure of
were washed with water using a magnet drawing Fe3O4 nanoparticles. polymers and functionalization of nanoparticles with biodegradable,
In the end, the Fe3O4 nanoparticles were redispersed in 10 mL of FTIR spectra were recorded of samples in the 400-4000 cm-1 region
deionized water while sonicating to form a stable brown colloid. in the transmission mode using an FT/IR-480 spectrometer at 4
These hydrophilic Fe3O4 nanoparticles in aqueous colloidal solution cm-1 resolution. The KBr compressed pellet method was adopted
were subsequently used for encapsulation or coating with a for solid samples, and a dropped liquid method using two transparent
biodegradable thermosensitive polymer. silicone glasses was used for liquid or solution samples.
Synthesis of Dextran Grafted with Poly(N-isopropylacryla- Determination of LCST of the Smart Polymer. The LCST
mide-co-N,N-dimethylacrylamide) [dextran-g-poly(NIPAAm-co- behavior of samples was determined using a UV-vis spectropho-
DMAAm)] Thermosensitive and Biodegradable Polymer (defined tometer (Lauda Brinkmann, Germany) equipped with a model Ecoline
as smart polymer). Dextran-g-poly(NIPAAm-co-DMAAm) was RE106 temperature controller. The change in transmittance as a
synthesized using the following four steps30 summarized in Scheme function of temperature was recorded using a 500 nm wavelength.
1. The first step is synthesis of the poly(NIPAAm-co-DMAAm)
with a methyl ester end group [STP-COOCH3]. The polymerization Results and Discussion
reaction was carried out by free radical copolymerization using methyl
3-mercaptopropionate as a chain transfer agent. NIPAAm (4.10 g), Characterization of the Hydrophobic Magnetite Nano-
DMAAm (0.95 mL), methyl 3-mercaptopropionate (80 µL), and particles. The transmission electron micrograph (TEM) of
2,2′-azobisisobutyronitrile (AIBN) (0.15 g) were dissolved in 50 hydrophobic magnetite nanoparticles and corresponding selected
mL of methanol and the solution bubbled with nitrogen gas for 30 area electron diffraction (SAED) pattern are presented in Figure
min. After the polymerization reaction at 50 °C for 24 h with stirring, 1. The TEM micrograph suggests that the hydrophobic nano-
the solution is concentrated and precipitated with excessive cold
diethyl ether. After filtration and drying at 50 °C, the final product,
particles are nearly spherical in shape. The monodisperse Fe3O4
STP-COOCH3, was obtained. nanoparticles shown in Figure 1a have a narrow particle size
distribution with the mean size of ∼5 nm. Figure 1b gives the
(31) Sun, S.; Zeng, H.; Robinson, D. B.; Raoux, S.; Rice, P. M.; Wang, S. X.; SAED pattern of the monodisperse Fe3O4 nanoparticles. The
Li, G. J. Am. Chem. Soc. 2004, 126, 273. indexing of the SAED pattern result, summarized in Table 1,
Encapsulated Core-Shell Nanoparticles Langmuir, Vol. 23, No. 11, 2007 6345
Scheme 1. Steps in the Synthesis of Dextran Grafted with Poly(NIPAAm-co-DMAAm) According to ref 30
indicates that the nanoparticles have a cubic crystal structure to enable design and tailoring of magnetic drug delivery systems
with the d-values of magnetite being consistent with the and magnetic resonance imaging contrast enhancement agents.
standard d-values listed in the X-ray powder JCPDS diffraction The Fe3O4 nanoparticles synthesized using the high-temperature
data file.32
Surface Properties of the Magnetite Nanoparticles. The (32) Berry, L. G.; Thompson, R. M. X-ray diffraction data for minerals; Waverly
surface properties of the magnetite nanoparticles are important Press: New York, 1962; p 194.
6346 Langmuir, Vol. 23, No. 11, 2007 Zhang et al.
Table 3. Assignment of FTIR Spectra of Dextran, 4-Nitrophenyl Chloroformate-Activated Dextran, and Poly(NIPAAm-co-DMAAm)
with an Amino End Group Presented in Figure 4
IR absorption
sample bands/cm-1 descriptiona
dextran 3700-3200 ν(H-O···H)
2926, 2897 ν(C-H) of -CH2
1639 δ(CH3)
1460, 1356 δ(H-C-OH)
1262 ν(C-O-CH2-)
1157, 846 νas(C-O-C) and νs(C-O-C)
1016 δ(O-H)
4-nitrophenyl 3700-3200 ν(H-O···H)
chloroformate-activated
dextran
2925, 2897 ν(C-H) of -CH2
1806 (i) ν(CdO)
1636 δ(CH3)
1461 δ(H-C-OH)
1523 (ii), 1341 (iii) νas(NdO) and νs(NdO)
1266 ν(C-O-CH2-)
1153, 852 νas(C-O-C) and νs(C-O-C)
1016 δ(O-H)
952 (iv) ν(C-N)
poly(NIPAAm-co-DMAAm) 3444, 3311 ν(N-H···H)
with an amino end group
2972, 2932, 2868 νas(C-H) and νs(C-H) of -CH3 and -CH2
1648 ν(CdO)
1543 δ(N-H)
1460 δ(H-C-OH)
1261 ν(C-O-CH2-)
660-600 ν(C-S)
dextran-g-poly(NIAAm-co- 3435 ν(O-H) and ν(N-H)
DMAAm) polymer
2971, 2929, 2871 νas(C-H) and νs(C-H)
1638 δ(CH3)
1542 δ(N-H)
1265 ν(C-O-CH2-)
1020 δ(O-H)
660-600 ν(C-S)
a
νs ) symmetric stretching vibration; νas ) asymmetric stretching vibration; δ ) bending vibration or deformation.
Scheme 2. Schematic Illustration of the Synthesis of Magnetic Carrier Coated with Smart Polymer
Magnetic capsules coated with polymers generally exhibit a magnet is presented. Upon application of an external magnetic
lower value of magnetization. The lower value is related to the field to the bottle filled with the magnetic capsules, the
overall reduction in the total ferrite content in the coated core- nanocapsules were attached on the side of the bottle that was
shell nanoparticles which gets reduced upon coating with polymer. in close proximity to the magnet, and the dispersion was clear
Detailed magnetic behavior of polymer-coated magnetic ferrites and transparent. Removal of the external magnetic field and
has been studied by us on previous occasions43,44 and is not redispersion by sonication led to the recovery of this dispersion,
discussed here, because it does not contribute the objective. implying that the magnetic capsules retained magnetism on
Also, the magnetic behavior of ferrites has been extensively incorporated with polymer. On the basis of analyses of the
discussed in the literature. However, we present here a simple above experimental results, the concept of synthesis and the
experiment to examine the retention of magnetism in magnetic schematic illustration of the experimental procedure of magnetic
capsules coated with smart polymer. In Figure 8, an optical carrier coated with smart polymer is schematically depicted in
photograph of the magnetic capsules attracted by an external Scheme 2.
We are now currently studying the drug release response and
(43) Nathani, H.; Gubbala, S.; Misra, R. D. K. Mater. Sci. Eng., B 2004, 111,
95. intercellular uptake of drug which will be reported in a followup
(44) Nathani, H.; Misra, R. D. K. Mater. Sci. Eng., B 2004, 113, 228. paper.
Encapsulated Core-Shell Nanoparticles Langmuir, Vol. 23, No. 11, 2007 6351
Conclusion DMAAm) shell. The unique and novel carrier combines the
In this study, a novel temperature-sensitive grafted biopolymer stimuli-responsive and biodegradable properties of the smart
with a LCST of ∼38 °C, dextran grafted with poly(N- polymer with the advantages of magnetic Fe3O4 nanoparticles,
isopropylacrylamide-co-N,N-dimethylacrylamide) [dextran-g- having potential applications in a magnetic drug-targeting delivery
poly(NIPAAm-co-DMAAm)], was successfully coated on the system for controlled drug release and contrast enhancement of
surface of hydrophilic magnetite nanoparticles to form a core- magnetic resonance imaging.
shell structure by cross-linking and intermolecular interaction.
The morphology of composite core-shell nanoparticles was Acknowledgment. The financial support for the work
spherical with a diameter of ∼8 nm. FTIR studies confirmed the presented here was obtained from CSFM.
appropriateness of the envisaged carrier characterized by a
magnetic Fe3O4 core and a dextran-g-poly(NIPAAm-co- LA0636199